Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & CofiledCriticalParke Davis & Co
Publication of BR6348807D0publicationCriticalpatent/BR6348807D0/en
New 2-guanidino-4-heterocyclyl-quinazoline derivatives, useful as sodium-proton antiporter subtype III inhibitors for treating e.g. respiratory, renal, ischemic or lipid metabolism disorders
COMPOUNDS DERIVED FROM 2- (REPLACED CILO) -1- (AMINO OR REPLACED OXI) -CHINAZOLINE, INHIBITORS OF IONIC SODIUM AND CALCIUM VOLTAGE DEPENDENTS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF ACUTE PAIN, CHRONIC, NEU
PROCESS FOR THE PRODUCTION OF 1,3,3-TRISUBSTITUTED 4PROCESS FOR THE PRODUCTION OF 1 3 3-TRISREPLACEMENT-4-(BETA-ETHYL-REPLACEMENT)-2-PYRROLIDINONE -(BETA-ETHYL-REPLACEMENT)-2-PENOLIDINONE